Stock Events

Stock Events

Quest Diagnostics 

€228.90
249
+€2.50+1.1%Friday 16:30

Statistics

Day High
229.4
Day Low
226.3
52W High
229.4
52W Low
201.9
Volume
117
Avg. Volume
-
Mkt Cap
25.26B
P/E Ratio
-
Dividend Yield
1.34%
Dividend
3.06

Upcoming

Dividends

1.34%Dividend Yield
Oct 2026
€0.77
Jul 2026
€0.75
Apr 2026
€0.73
Jan 2026
€0.67
Oct 2025
€0.69
10Y Growth
7.39%
5Y Growth
7.44%
3Y Growth
4.59%
1Y Growth
4.73%

Earnings

Feb 4Expected
Q2 2026
Q3 2026
Next
2.39
2.51
2.62
2.74
Expected EPS
2.3904646405
Actual EPS
N/A

Financials

8.97%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
9.58BRevenue
860.13MNet Income

Analyst Ratings

$193.49Average Price Target
The highest estimate is ⁦197.29⁩.
From 6 ratings within the last 6 months. This is not an investment recommendation.
Buy
33%
Hold
67%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow QDI.XETRA. It's not an investment recommendation.
Apple
63
AAPL
Microsoft
59
MSFT
Johnson & Johnson
54
JNJ
Realty Income
51
O

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Labcorp
LH
Mkt Cap22.7B
Laboratory Corporation of America Holdings operates as a direct competitor, offering similar clinical laboratory and end-to-end drug development services.
Bio-Rad Laboratories
BIO
Mkt Cap9.95B
Bio-Rad Laboratories, Inc. provides a range of products and systems used to separate complex chemical and biological materials, directly competing in the diagnostics and research market.
Thermo Fisher Scientific
TMO
Mkt Cap257.71B
Thermo Fisher Scientific Inc. offers similar diagnostic test products and services, competing in the life sciences and healthcare sectors.
Danaher
DHR
Mkt Cap163.25B
Danaher Corporation operates in the diagnostics and research sector, offering products and services that compete with Quest Diagnostics in the healthcare diagnostics field.
Agilent Technologies
A
Mkt Cap49.3B
Agilent Technologies, Inc. provides instruments, services, consumables, applications, and expertise, competing in the life sciences and diagnostics sectors.
Guardant Health
GH
Mkt Cap23.99B
Guardant Health, Inc. specializes in liquid biopsy tests, which are part of the growing diagnostics market, competing with Quest Diagnostics in cancer diagnostics.
Neogenomics
NEO
Mkt Cap2.25B
NeoGenomics, Inc. specializes in cancer diagnostics and pharma services, directly competing with Quest Diagnostics in the oncology diagnostics market.
Myriad Genetics
MYGN
Mkt Cap607.38M
Myriad Genetics, Inc. focuses on molecular diagnostic tests, competing in the personalized medicine and genetic testing market.

About

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
Show More
CEO
James E. Davis
Employees
57000
Country
United States
ISIN
US74834L1008
WKN
000904533

Listings

MI
IT
1QDX.MI
STU
DE
QDI.STU
LSE
GB
0KSX.LSE
F
DE
QDI.F

0 Comments

Share your thoughts

FAQs

What is Quest Diagnostics stock price today?▼
The current price of QDI.XETRA is €228.90 EUR — it has increased by +1.1% in the past 24 hours. Watch Quest Diagnostics stock price performance more closely on the chart.
What is Quest Diagnostics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XETRA Stock Exchange exchange Quest Diagnostics stocks are traded under the ticker QDI.XETRA.
What is Quest Diagnostics market cap?▼
Today Quest Diagnostics has the market capitalization of 25.26B
When is the next Quest Diagnostics earnings date?▼
Quest Diagnostics is going to release the next earnings report on February 4, 2027.
What were Quest Diagnostics earnings last quarter?▼
QDI.XETRA earnings for the last quarter are 2.67 EUR per share, whereas the estimation was 2.56 EUR resulting in a +4.35% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Quest Diagnostics revenue for the last year?▼
Quest Diagnostics revenue for the last year amounts to 9.58B EUR.
What is Quest Diagnostics net income for the last year?▼
QDI.XETRA net income for the last year is 860.13M EUR.
Does Quest Diagnostics pay dividends?▼
Yes, QDI.XETRA dividends are paid quarterly. The last dividend per share was 0.77 . As of today, Dividend Yield (FWD)% is 1.34%.
How many employees does Quest Diagnostics have?▼
As of November 7, 2026, the company has 57,000 employees.
In which sector is Quest Diagnostics located?▼
Quest Diagnostics operates in the Health & Wellness sector.
When did Quest Diagnostics complete a stock split?▼
The last stock split for Quest Diagnostics was on June 21, 2005 with a ratio of 2:1.
Where is Quest Diagnostics headquartered?▼
Quest Diagnostics is headquartered in SECAUCUS, United States.